These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 34755033)

  • 41. Finger clubbing in inflammatory bowel disease: association with upper small bowel lesions and need of surgery in Crohn's disease.
    Romeo S; Neri B; Mossa M; Calabrese E; Lolli E; Sena G; Gesuale C; Chiaramonte C; Biancone L
    Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):844-851. PubMed ID: 33136723
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of the COVID-19 pandemic on inflammatory bowel disease patients: A review of the current evidence.
    Kumric M; Ticinovic Kurir T; Martinovic D; Zivkovic PM; Bozic J
    World J Gastroenterol; 2021 Jul; 27(25):3748-3761. PubMed ID: 34321841
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey.
    Nakase H; Wagatsuma K; Nojima M; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Takeuchi K; Tamura S; Kinjo F; Ueno N; Naganuma M; Watanabe K; Moroi R; Nishimata N; Motoya S; Kurahara K; Takahashi S; Maemoto A; Sakuraba H; Saruta M; Tominaga K; Hisabe T; Tanaka H; Terai S; Hiraoka S; Takedomi H; Narimatsu K; Endo K; Nakamura M; Hisamatsu T
    J Gastroenterol; 2023 Mar; 58(3):205-216. PubMed ID: 36607399
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease.
    Graff LA; Geist R; Kuenzig ME; Benchimol EI; Kaplan GG; Windsor JW; Bitton A; Coward S; Jones JL; Lee K; Murthy SK; Peña-Sánchez JN; Targownik LE; Jannati N; Jones May T; Akhtar Sheekha T; Davis T; Weinstein J; Dahlwi G; Im JHB; Amankwah Osei J; Rohatinsky N; Ghandeharian S; Goddard Q; Gorospe J; Gertsman S; Louis M; Wagner R; Brass C; Sanderson R; Bernstein CN
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S64-S75. PubMed ID: 37674499
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Canadian Consensus Statements on the Transition of Adolescents and Young Adults with Inflammatory Bowel Disease from Pediatric to Adult Care: A Collaborative Initiative Between the Canadian IBD Transition Network and Crohn's and Colitis Canada.
    Fu N; Bollegala N; Jacobson K; Kroeker KI; Frost K; Afif W; El-Matary W; Fowler SA; Griffiths AM; Huynh HQ; Jantchou P; Karimuddin A; Nguyen GC; Otley AR; Pears C; Seow CH; Toulany A; Tersigni C; Tignanelli J; Marshall JK; Boctor M; Hansen T; Pattni C; Wong A; Benchimol EI
    J Can Assoc Gastroenterol; 2022 Jun; 5(3):105-115. PubMed ID: 35669843
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients.
    Barreiro-de Acosta M; Marín-Jiménez I; Panadero A; Guardiola J; Cañas M; Gobbo Montoya M; Modino Y; Alcaín G; Bosca-Watts MM; Calvet X; Casellas F; Chaparro M; Fernández Salazar L; Ferreiro-Iglesias R; Ginard D; Iborra M; Manceñido N; Mañosa M; Merino O; Rivero M; Roncero O; Sempere L; Vega P; Zabana Y; Mínguez M; Nos P; Gisbert JP
    Gastroenterol Hepatol; 2018 Feb; 41(2):118-127. PubMed ID: 29275001
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The 2023 Impact of Inflammatory Bowel Disease in Canada: Indirect (Individual and Societal) and Direct Out-of-Pocket Costs.
    Kuenzig ME; Im JHB; Coward S; Windsor JW; Kaplan GG; Murthy SK; Benchimol EI; Bernstein CN; Bitton A; Jones JL; Lee K; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Jones May T; Tabatabavakili S; Jogendran R; Weinstein J; Khan R; Hazan E; Browne M; Davis T; Goddard Q; Gorospe J; Latos K; Mason K; Kerr J; Balche N; Sklar A; Targownik LE
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S16-S22. PubMed ID: 37674495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. COVID-19 Vaccination Among Individuals With Inflammatory Bowel Disease: Perception, Efficacy, and Safety.
    Weaver KN; Kappelman MD; Long MD
    Gastroenterol Hepatol (N Y); 2022 Jul; 18(7):388-399. PubMed ID: 36397773
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk and outcomes of coronavirus disease in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    Singh AK; Jena A; Kumar-M P; Sharma V; Sebastian S
    United European Gastroenterol J; 2021 Mar; 9(2):159-176. PubMed ID: 33210980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The 2023 Impact of Inflammatory Bowel Disease in Canada: Direct Health System and Medication Costs.
    Kuenzig ME; Coward S; Targownik LE; Murthy SK; Benchimol EI; Windsor JW; Bernstein CN; Bitton A; Jones JL; Lee K; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Im JHB; Jogendran R; Meka S; Weinstein J; Jones May T; Jogendran M; Tabatabavakili S; Hazan E; Hu M; Osei JA; Khan R; Wang G; Browne M; Davis T; Goddard Q; Gorospe J; Latos K; Mason K; Kerr J; Balche N; Sklar A; Kaplan GG
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S23-S34. PubMed ID: 37674493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in Switzerland.
    Schoepfer A; Vavricka SR; Brüngger B; Blozik E; Bähler C
    Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):350-357. PubMed ID: 31834046
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Common contributing factors to COVID-19 and inflammatory bowel disease.
    Kostoff RN; Briggs MB; Kanduc D; Shores DR; Kovatsi L; Vardavas AI; Porter AL
    Toxicol Rep; 2021; 8():1616-1637. PubMed ID: 34485092
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trends in the epidemiology of inflammatory bowel disease among Jewish Israeli adolescents: a population-based study.
    Ghersin I; Khteeb N; Katz LH; Daher S; Shamir R; Assa A
    Aliment Pharmacol Ther; 2019 Mar; 49(5):556-563. PubMed ID: 30687945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry.
    Agrawal M; Brenner EJ; Zhang X; Colombel JF; Kappelman MD; Ungaro RC; ; Gearry RB; Kalpan GG; Kissous-Hunt M; Lewis JD; Ng SC; Rahier JF; Reinisch W; Ruemmele FM; Steinwurz F; Underwood FE
    J Crohns Colitis; 2021 May; 15(5):860-863. PubMed ID: 33232456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The 2023 Impact of Inflammatory Bowel Disease in Canada: Special Populations-IBD in Seniors.
    Shaffer SR; Kuenzig ME; Windsor JW; Bitton A; Jones JL; Lee K; Murthy SK; Targownik LE; Peña-Sánchez JN; Rohatinsky N; Ghandeharian S; Tandon P; St-Pierre J; Natt N; Davis T; Weinstein J; Im JHB; Benchimol EI; Kaplan GG; Goddard Q; Gorospe J; Bergevin M; Silver K; Bowles D; Stewart M; Pearlstein M; Dawson EH; Bernstein CN
    J Can Assoc Gastroenterol; 2023 Sep; 6(Suppl 2):S45-S54. PubMed ID: 37674503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
    Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammatory Bowel Disease Patients' Perspectives during COVID-19 Pandemic: Results from a Portuguese Survey.
    Revés JB; Frias-Gomes C; Morão B; Nascimento C; Palmela C; Fidalgo C; Roque Ramos L; Sampaio A; Glória L; Cravo M; Torres J
    GE Port J Gastroenterol; 2021 Sep; 5(5):1-9. PubMed ID: 34934777
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic determinants associated with early age of diagnosis of IBD.
    Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
    Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.